Effects of Cannabigerol on Psychological and Physiological Outcomes
Psychological and Physiological Effects of Cannabigerol (CBG)
This study is testing how cannabigerol (CBG) affects things like mood, anxiety, and heart rate in healthy adults to see if it has any good or bad effects on their health.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 21 Years and up |
| Sex | All |
| Sponsor | Washington State University Academic / other |
| Locations | 1 site (Pullman, Washington) |
| Trial ID | NCT06638996 on ClinicalTrials.gov |
What this trial studies
This study investigates the acute effects of cannabigerol (CBG) on various psychological and physiological outcomes in healthy adults. Participants aged 21 and older will be recruited and randomly assigned to receive either a CBG tincture or a placebo in two separate testing sessions. The study will assess outcomes such as anxiety, stress, mood, memory, heart rate, and potential side effects like sleepiness and dry mouth. The goal is to better understand both the beneficial and detrimental effects of CBG on human health.
Who should consider this trial
Good fit: Ideal candidates are healthy adults aged 21 and older who are fluent in English and do not have serious psychiatric or neurological disorders.
Not a fit: Patients with serious psychiatric disorders, neurological conditions, or those who are pregnant or breastfeeding may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide insights into the therapeutic potential of CBG for managing stress and anxiety.
How similar studies have performed: While studies on cannabinoids have been conducted, the specific focus on CBG's acute effects is relatively novel and less explored.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 21+ years of age Fluent in English Exclusion Criteria: Illiterate Serious psychiatric disorders (i.e., psychotic disorders, bipolar disorders) Intellectual disability Chronic neurological disorders (e.g., head injuries, brain tumors, Parkinson's disease) Diabetes Low blood pressure Pregnant or breastfeeding Recent illicit drug use (past 2 months) - does not include cannabis Dietary restrictions preventing them from eating muffin, yogurt, milk/juice
Where this trial is running
Pullman, Washington
- Washington State University - Pullman Campus — Pullman, Washington, United States (Recruiting)
Study contacts
- Study coordinator: Carrie Cuttler Dr. Cuttler, Ph.D., Psychology
- Email: carrie.cuttler@wsu.edu
- Phone: (509) 335-0151
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.